2nd TPD Assay Development & Screening Summit
Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development & Screening Summit returns as the only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.
With promise shown using technologies like DELs, CryoEM and HDX-MS, join us as we take a deep dive into the persisting challenges holding back the progression of candidates into pre-clinical studies by exploring the best methodologies at your disposal across AI/ML guided structure-based drug design, proteomics-led, or cell-based assay approaches.
Snapshot of expert speakers:
- Anand Ramanathan, Associate Director - Discovery Lead, Kymera Therapeutics
- Bradley DeMarco, Senior Scientist, Monte Rosa Therapeutics
- Justin Reitsma, Principle Research Scientist, Abbvie
- Michelle Arkin, Professor and Chair, Pharmaceutical Chemistry, University of California San Francisco
- Peggy Thompson, Vice President of Biology, Plexium
- Prakash Palde, Associate Research Fellow (Director Level Position), Pfizer
